Professional Documents
Culture Documents
KSA-Pharma Strategy PDF
KSA-Pharma Strategy PDF
Bioequivalence
Biosimilars Sterile Injectables APIs centers
Vaccine
Research, developing and producing vaccines against pandemics • National security
Institute
Solid Oral Formulation, and packaging of generic SODs for high volume products, top off-
• GDP & Jobs
Dosage patent products and products with shortages
Bio-
Build the required number of bioequivalence centers to ensure that the drugs which
Equivalence • National security
are produced locally are comparable to international standards
Centers
Partial engineering, bulk manufacturing and fill & finish of off-patent
Biosimilars biological drugs with primary focus on insulin analog, autoimmune and • Knowledge
oncology
Sterile Formulation, filling and packaging for chemical drugs and biologics to address
• Knowledge
Injectables segments such as oncology, anti-infectives, cardiovascular and musculoskeletal
Production of APIs that are consumed locally in high volume as well as off patent
APIs • Knowledge
originator drugs